{"id":48518,"date":"2022-09-17T01:01:36","date_gmt":"2022-09-16T23:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/"},"modified":"2022-09-17T01:01:36","modified_gmt":"2022-09-16T23:01:36","slug":"ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/","title":{"rendered":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million"},"content":{"rendered":"
\n

\nMonday, Sept. 19, 10 a.m. PDT \/ 1 p.m. EDT via Zoom<\/i><\/b>\n<\/p>\n

LOS ANGELES–(BUSINESS WIRE)–The United States District Court for the District of Arizona has confirmed an earlier arbitration judgment of $23 million awarded to AIDS Healthcare Foundation (AHF) against Caremark LLC, a subsidiary of the pharmacy giant CVS, for unfair reimbursement practices.\n<\/p>\n

\nAHF<\/a> will host a virtual press conference<\/b> via Zoom on Monday, Sept. 19 at 10 a.m. PDT \/ 1 p.m. EDT<\/b>. AHF President Michael Weinstein<\/b> will deliver remarks on the outcome of the dispute and attorneys representing AHF in Caremark LLC v. AIDS Healthcare Foundation<\/b> will be on hand to answer questions.\n<\/p>\n\n\n\n\n\n\n\n
\n

\nWHAT:<\/b>\n<\/p>\n<\/td>\n

\n

\nVirtual Press Conference.
\n
AHF awarded a $23 million judgment against a CVS subsidiary.\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWHEN:<\/b>\n<\/p>\n<\/td>\n

\n

\nMonday, Sept. 19, 2022 at 10 a.m. PDT \/ 1 p.m. EDT\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWHERE:<\/b>\n<\/p>\n<\/td>\n

\n

\nAttend via Zoom: https:\/\/ahf-org.zoom.us\/j\/81109693861<\/a>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWHO:<\/b>\n<\/p>\n<\/td>\n

\n
    \n
  • \nMichael Weinstein, AHF President\n<\/li>\n
  • \nTom Myers, AHF General Counsel\n<\/li>\n
  • \nAndrew Kim, Attorney at Kim Riley Law, representing AHF\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\n

\nNEWS DESK NOTE & B-ROLL VISUALS<\/b>\n<\/p>\n<\/td>\n

\n
\n

\nMEDIA CONTACTS:<\/b>\n<\/p>\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nDenys Nazarov, Senior Director of Media Relations, AHF\n<\/p>\n

\n(323) 219-1091 | denys.nazarov@ahf.org<\/a><\/p>\n

<\/span>Ged Kenslea, Senior Director of Communications, AHF\n<\/p>\n

\n(323) 791-5526 | ged.kenslea@ahf.org<\/a>\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nBackground:<\/b> In November 2019, AHF filed suit with the American Arbitration Association against Caremark LLC, a pharmacy benefits manager (PBM), for breach of agreement and the covenant of good faith and fair dealing. The dispute arose from Caremark\u2019s unfair practice of charge-backs on prescriptions filled by AHF pharmacies on behalf of insurance prescription plan sponsors such as those covering Medicare Plan D beneficiaries.\n<\/p>\n

\nAs a result of the charge-backs by Caremark, for a number of years AHF was being reimbursed less than what Part D plan sponsors received in prescription reimbursement from public Part D monies. In November 2021, the arbitrator ruled in favor of AHF and ordered Caremark to reimburse AHF nearly $23 million in damages and arbitration expenses. Subsequently, in November 2021 Caremark filed a court motion to vacate or correct the arbitration award, however on Sept. 15, 2022 the United States District Court for the District of Arizona upheld AHF\u2019s arbitration award.\n<\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDenys Nazarov, Senior Director of Media Relations, AHF
\n
(323) 219-1091 | denys.nazarov@ahf.org<\/a><\/p>\n

Ged Kenslea, Senior Director of Communications, AHF
\n
(323) 791-5526 | ged.kenslea@ahf.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Monday, Sept. 19, 10 a.m. PDT \/ 1 p.m. EDT via Zoom LOS ANGELES–(BUSINESS WIRE)–The United States District Court for the District of Arizona has confirmed an earlier arbitration judgment of $23 million awarded to AIDS Healthcare Foundation (AHF) against Caremark LLC, a subsidiary of the pharmacy giant CVS, for unfair reimbursement practices. AHF will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48518","6":"format-standard","7":"category-industry"},"yoast_head":"\nAHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Monday, Sept. 19, 10 a.m. PDT \/ 1 p.m. EDT via Zoom LOS ANGELES–(BUSINESS WIRE)–The United States District Court for the District of Arizona has confirmed an earlier arbitration judgment of $23 million awarded to AIDS Healthcare Foundation (AHF) against Caremark LLC, a subsidiary of the pharmacy giant CVS, for unfair reimbursement practices. AHF will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-16T23:01:36+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AHF Press Conference: CVS Ordered to Compensate AHF $23 million\",\"datePublished\":\"2022-09-16T23:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/\"},\"wordCount\":490,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/\",\"name\":\"AHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-09-16T23:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AHF Press Conference: CVS Ordered to Compensate AHF $23 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/","og_locale":"en_US","og_type":"article","og_title":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend","og_description":"Monday, Sept. 19, 10 a.m. PDT \/ 1 p.m. EDT via Zoom LOS ANGELES–(BUSINESS WIRE)–The United States District Court for the District of Arizona has confirmed an earlier arbitration judgment of $23 million awarded to AIDS Healthcare Foundation (AHF) against Caremark LLC, a subsidiary of the pharmacy giant CVS, for unfair reimbursement practices. AHF will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-16T23:01:36+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million","datePublished":"2022-09-16T23:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/"},"wordCount":490,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/","url":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/","name":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-09-16T23:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ahf-press-conference-cvs-ordered-to-compensate-ahf-23-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AHF Press Conference: CVS Ordered to Compensate AHF $23 million"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48518"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48518\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}